HDAC Inhibitors Finally Open Up: Chromatin Accessibility Signatures of CTCL

Publication date: 10 July 2017
Source:Cancer Cell, Volume 32, Issue 1
Author(s): Christopher J. Ott, Catherine J. Wu
In this issue of Cancer Cell, Qu et al. describe the chromatin accessibility profiles of cutaneous T cell lymphoma, with dynamic assessments of response and resistance to histone deacetylase inhibitor therapy. Their "personal regulome" analysis framework reveals chromatin features that may be predictive of clinical response to epigenetic therapy.

Teaser

In this issue of Cancer Cell, Qu et al. describe the chromatin accessibility profiles of cutaneous T cell lymphoma, with dynamic assessments of response and resistance to histone deacetylase inhibitor therapy. Their "personal regulome" analysis framework reveals chromatin features that may be predictive of clinical response to epigenetic therapy.


http://ift.tt/2v6cJ8l